HCPCS code Q2057 — Afamitresgene autoleucel. Status: Active. Effective Jan 1, 2026. Source: CMS HCPCS Level II.

Q2057

Active

Afamitresgene autoleucel

Afamitresgene autoleucel, including leukapheresis and dose preparation procedures, per therapeutic dose

Category: Temporary
Section: Q-codes: Temporary Codes
Effective: Jan 1, 2026
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 2067

MUE — Medically Unlikely Edits

Maximum units of Q2057 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 1
Practitioner Services 1

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
83205-0001-02 Tecelra

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • New Code 2026-Q1
    Afamitresgene autoleucel